Potent agonist and antagonist analogues of luliberin containing an azaglycine residue in position 10.
D000728:Androgens; D000818:Animals; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D004971:Estrus; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D009929:Organ Size / Q000187:drug effects; D010053:Ovary / Q000187:drug effects; D010062:Ovulation Induction; D011247:Pregnancy; D051381:Rats; D013329:Structure-Activity Relationship; D014599:Uterus / Q000187:drug effects
D000728:Androgens; D006063:Chorionic Gonadotropin; D007987:Gonadotropin-Releasing Hormone